EGFR and its downstream signaling pathways involving MEK/ERK, p38 MAPK, and PI3K/Akt play key roles in the proliferation and differentiation of normal epithelial cells and has been associated with the development of tumor, especially lung cancer [3, 38]. This evidence concerns the gene EGFR and lung carcinoma.